Yu, L. A., Ning, F., Zhou, Z., Li, J., Chen, G., Peng, P., Zhang, H., Sun, Y., Hsieh, C., Luk, A., Zhang, V., Sun, D. (2026). Dose-dependent antitumor activity of HCB101 plus ramucirumab and paclitaxel in previously treated gastric cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.372